FDA-cleared shockwave technology
SoftWave be effective in reducing or managing the symptoms by decreasing pain, temporarily increasing blood supply, and activating connective tissue for:
Shockwave Therapy, or Extracorporeal Shockwave Therapy (EWST), is a non-invasive treatment that involves the delivery of shockwaves to an injured area to promote healing. This treatment produces highly effective shockwaves that initiate biological regeneration processes at the cellular level. SoftWave technology applies short, frequent, and high intensity bursts of mechanical energy (in the form of a shockwave) into soft-tissue that is injured, scarred, or contains adhesions, is painful, or inflamed. The use of therapeutic energy waves to activate the body’s natural healing is safe, doesn’t require surgery, drugs, or needles, and helps reduce pain and speed up recovery.
SoftWave technology allows us to pinpoint treatment areas accurately through real-time patient feedback. This precise targeting can improve your treatment outcomes and efficiency.
SoftWave technology utilizes short high-intensity acoustic waves to stimulate the body’s natural healing processes at the cellular and tissue level.
Shockwaves energy generates a large positive pressure wave followed by a negative pressure wave.
Mechanical stimulus leads to biochemical reactions. Biomolecules are released and cell signaling is activated.
Angiogenesis, inflammatory modulation, stimulation of tissue regeneration.
Fluorescent stained mitochondria before and after broad-focused shockwave therapy.
Angiogenesis changes before and after shockwave therapy.
Focused/Broad Focused
Focused
Focused
SoftWave therapy requires the least number of shocks, the fewest treatments, and superior outcomes with the least pain at energy levels that do not cause cellular trauma or injury.
